Actigen

Actigen is a contract research organisation specialising in the design and delivery of clinical trials for rare and orphan diseases.

Working in partnership with therapy developers and patient advocacy groups, the company employs inventive trial designs to accelerate development of medicines for conditions with significant unmet medical need.

Its current programme is focused on clinical trials for mucopolysaccharidosis II in collaboration with an international biologics partner.